Greek University uses Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage

Photo by Lucija Ros

The Aristotle University Of Thessaloniki is enrolling patients into the clinical trial investigating Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage (DermaSense).

This is a clinical study designed to evaluate if the DermaSense device can be a system of an automated analysis and classification of skin lesions aiming to provide a comprehensive, reliable and cost-effective approach to assist the Dermatologists' decision (biopsy, dermoscopy, histopathological analysis etc). Second Department of Dermatology, School of Medicine, Faculty of Health Sciences of the Aristotle University of Thessaloniki, at the "Papageorgiou" General Hospital will participate in this study. Dermatologists participating in the study will perform the patient and lesion assessment for biopsy as standard of care at the clinic.

EIS (electrical impedance spectroscopy) measurements will be done once per participant recommended by the Dermatologist based on their clinical interest in various areas of the skin. Evaluation and analysis of the measurement data will be done by the DermaSense team and will be used not only for applying appropriate statistical correlations compared to established dermatological diagnostic methods but also for training in artificial intelligence and machine learning methods.

The trial is designed to enroll male and female 8 to 90 years and is being conducted in the Laboratory of Medical Physics, AUTH, Thessaloniki, Greece.

The study start date is July 17, 2019.

This page provides a more detailed overview of this clinical trial:

Clinical Research News

Upcoming Clinical Trials